Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hohlfeld

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Deutsche Medizinische Wochenschrift (1946)|July 24, 1992
[Tumor necrosis factor and multiple sclerosis]S Schönbeck, R Hohlfeld
Der Nervenarzt|January 19, 2000
[Neurology 2000. From the molecule to the system]R Hohlfeld, T Brandt
Journal of Neuroimmunology|February 16, 2000
T cell transformation with Herpesvirus saimiri: a tool for neuroimmunological researchE Meinl, R Hohlfeld
MMW, Munchener Medizinische Wochenschrift|July 31, 1981
[Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)]R Hohlfeld, H Wekerle
Der Nervenarzt|April 1, 1995
[Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?]S Schmidt, R Hohlfeld
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1970
[Histochemical findings on the gastric mucosa following administration of antibiotics]R Hohlfeld, H Petzold
Nature: New Biology|April 4, 1973
Bidirectional growth of the E. coli chromosomeR Hohlfeld, W Vielmetter
International MS Journal|August 9, 2003
Neurotrophic factors protect myelin from attackM Kerschensteiner, R Hohlfeld
Advances in Neuroimmunology|January 1, 1994
The role of the thymus in myasthenia gravisR Hohlfeld, H Wekerle
Der Nervenarzt|June 1, 1993
[Current therapy of multiple sclerosis. Oral tolerance induction to myelin antigens]R Voltz, R Hohlfeld
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Deutsche Medizinische Wochenschrift (1946)|July 24, 1992
[Tumor necrosis factor and multiple sclerosis]S Schönbeck, R Hohlfeld
Der Nervenarzt|January 19, 2000
[Neurology 2000. From the molecule to the system]R Hohlfeld, T Brandt
Journal of Neuroimmunology|February 16, 2000
T cell transformation with Herpesvirus saimiri: a tool for neuroimmunological researchE Meinl, R Hohlfeld
MMW, Munchener Medizinische Wochenschrift|July 31, 1981
[Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)]R Hohlfeld, H Wekerle
Der Nervenarzt|April 1, 1995
[Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?]S Schmidt, R Hohlfeld
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1970
[Histochemical findings on the gastric mucosa following administration of antibiotics]R Hohlfeld, H Petzold
Nature: New Biology|April 4, 1973
Bidirectional growth of the E. coli chromosomeR Hohlfeld, W Vielmetter
International MS Journal|August 9, 2003
Neurotrophic factors protect myelin from attackM Kerschensteiner, R Hohlfeld
Advances in Neuroimmunology|January 1, 1994
The role of the thymus in myasthenia gravisR Hohlfeld, H Wekerle
Der Nervenarzt|June 1, 1993
[Current therapy of multiple sclerosis. Oral tolerance induction to myelin antigens]R Voltz, R Hohlfeld
Pageof 21